These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 12584562

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Blocking HER-2/HER-3 function with a dominant negative form of HER-3 in cells stimulated by heregulin and in breast cancer cells with HER-2 gene amplification.
    Ram TG, Schelling ME, Hosick HL.
    Cell Growth Differ; 2000 Mar; 11(3):173-83. PubMed ID: 10768865
    [Abstract] [Full Text] [Related]

  • 4. The integrin, alpha6beta1, is necessary for the matrix-dependent activation of FAK and MAP kinase and the migration of human hepatocarcinoma cells.
    Carloni V, Mazzocca A, Pantaleo P, Cordella C, Laffi G, Gentilini P.
    Hepatology; 2001 Jul; 34(1):42-9. PubMed ID: 11431732
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. ERBB2-mediated transcriptional up-regulation of the alpha5beta1 integrin fibronectin receptor promotes tumor cell survival under adverse conditions.
    Spangenberg C, Lausch EU, Trost TM, Prawitt D, May A, Keppler R, Fees SA, Reutzel D, Bell C, Schmitt S, Schiffer IB, Weber A, Brenner W, Hermes M, Sahin U, Türeci O, Koelbl H, Hengstler JG, Zabel BU.
    Cancer Res; 2006 Apr 01; 66(7):3715-25. PubMed ID: 16585198
    [Abstract] [Full Text] [Related]

  • 7. Aberrant expression of integrin and erbB subunits in breast cancer cell lines.
    Shimizu H, Koyama N, Asada M, Yoshimatsu K.
    Int J Oncol; 2002 Nov 01; 21(5):1073-9. PubMed ID: 12370757
    [Abstract] [Full Text] [Related]

  • 8. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.
    Sawai H, Okada Y, Funahashi H, Matsuo Y, Takahashi H, Takeyama H, Manabe T.
    BMC Cell Biol; 2006 Feb 20; 7():8. PubMed ID: 16504015
    [Abstract] [Full Text] [Related]

  • 9. Grb2 downregulation leads to Akt inactivation in heregulin-stimulated and ErbB2-overexpressing breast cancer cells.
    Lim SJ, Lopez-Berestein G, Hung MC, Lupu R, Tari AM.
    Oncogene; 2000 Dec 14; 19(54):6271-6. PubMed ID: 11175341
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Overexpression of ErbB2 enhances ethanol-stimulated intracellular signaling and invasion of human mammary epithelial and breast cancer cells in vitro.
    Ma C, Lin H, Leonard SS, Shi X, Ye J, Luo J.
    Oncogene; 2003 Aug 14; 22(34):5281-90. PubMed ID: 12917629
    [Abstract] [Full Text] [Related]

  • 12. Induction or suppression of expression of cytochrome C oxidase subunit II by heregulin beta 1 in human mammary epithelial cells is dependent on the levels of ErbB2 expression.
    Sun Y, Lin H, Zhu Y, Ma C, Ye J, Luo J.
    J Cell Physiol; 2002 Aug 14; 192(2):225-33. PubMed ID: 12115729
    [Abstract] [Full Text] [Related]

  • 13. Epidermal growth factor-induced ovarian carcinoma cell migration is associated with JAK2/STAT3 signals and changes in the abundance and localization of alpha6beta1 integrin.
    Colomiere M, Findlay J, Ackland L, Ahmed N.
    Int J Biochem Cell Biol; 2009 May 14; 41(5):1034-45. PubMed ID: 18930836
    [Abstract] [Full Text] [Related]

  • 14. Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-beta1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling.
    Pan MH, Lin CC, Lin JK, Chen WJ.
    J Agric Food Chem; 2007 Jun 27; 55(13):5030-7. PubMed ID: 17539658
    [Abstract] [Full Text] [Related]

  • 15. Selective hormone-dependent repression of estrogen receptor beta by a p38-activated ErbB2/ErbB3 pathway.
    St-Laurent V, Sanchez M, Charbonneau C, Tremblay A.
    J Steroid Biochem Mol Biol; 2005 Feb 27; 94(1-3):23-37. PubMed ID: 15862947
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. HDAC inhibitor SNDX-275 induces apoptosis in erbB2-overexpressing breast cancer cells via down-regulation of erbB3 expression.
    Huang X, Gao L, Wang S, Lee CK, Ordentlich P, Liu B.
    Cancer Res; 2009 Nov 01; 69(21):8403-11. PubMed ID: 19826038
    [Abstract] [Full Text] [Related]

  • 18. Beta 4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis.
    Guo W, Pylayeva Y, Pepe A, Yoshioka T, Muller WJ, Inghirami G, Giancotti FG.
    Cell; 2006 Aug 11; 126(3):489-502. PubMed ID: 16901783
    [Abstract] [Full Text] [Related]

  • 19. Macrophage inhibitory cytokine-1 activates AKT and ERK-1/2 via the transactivation of ErbB2 in human breast and gastric cancer cells.
    Kim KK, Lee JJ, Yang Y, You KH, Lee JH.
    Carcinogenesis; 2008 Apr 11; 29(4):704-12. PubMed ID: 18258606
    [Abstract] [Full Text] [Related]

  • 20. ErbB2 and EGFR are downmodulated during the differentiation of 3T3-L1 preadipocytes.
    Pagano E, Calvo JC.
    J Cell Biochem; 2003 Oct 15; 90(3):561-72. PubMed ID: 14523990
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.